Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-15

FDA Approved: DOXERCALCIFEROL — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved an original application for doxercalciferol as a generic drug, expanding access to this vitamin D analog.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXERCALCIFEROL (Doxercalciferol)

Snippet

ORIG AP for DOXERCALCIFEROL (DOXERCALCIFEROL)